Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1984 Aug;47(8):813–819. doi: 10.1136/jnnp.47.8.813

Plasma exchange treatment of peripheral neuropathy associated with plasma cell dyscrasia.

W H Sherman, M R Olarte, G McKiernan, K Sweeney, N Latov, A P Hays
PMCID: PMC1027944  PMID: 6470723

Abstract

Plasma exchange was used to treat 10 patients with polyneuropathy and a monoclonal antibody (plasma cell dyscrasia). Six patients had improvement of the neuropathy, while three patients had stabilisation of the neuropathy during plasma exchange. The patients who improved maintained a 64% or greater decrease in the monoclonal antibody between exchanges. Patients with axonal polyneuropathy as well as patients with demyelinating polyneuropathy recovered some neurologic function. With cessation of plasma exchanges, the monoclonal antibody titre approached pre-treatment levels and the neuropathy progressed. Plasma exchange was effective in rapidly lowering the level of monoclonal antibody and allowing for some recovery of neurologic function.

Full text

PDF
813

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergsagel D. E., Bailey A. J., Langley G. R., MacDonald R. N., White D. F., Miller A. B. The chemotherapy on plasma-cell myeloma and the incidence of acute leukemia. N Engl J Med. 1979 Oct 4;301(14):743–748. doi: 10.1056/NEJM197910043011402. [DOI] [PubMed] [Google Scholar]
  2. Besinger U. A., Toyka K. V., Anzil A. P., Fateh-Mognadam A., Rouscher R., Heininger K. Myeloma neuropathy: passive transfer from man to mouse. Science. 1981 Aug 28;213(4511):1027–1030. doi: 10.1126/science.7268405. [DOI] [PubMed] [Google Scholar]
  3. Buskard N. A., Galton D. A., Goldman J. M., Kohner E. M., Grindle C. F., Newman D. L., Twinn K. W., Lowenthal R. M. Plasma exchange in the long-term management of Waldenström's macroglobulinemia. Can Med Assoc J. 1977 Jul 23;117(2):135–137. [PMC free article] [PubMed] [Google Scholar]
  4. Dalakas M. C., Engel W. K. Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment. Ann Neurol. 1981;9 (Suppl):134–145. doi: 10.1002/ana.410090719. [DOI] [PubMed] [Google Scholar]
  5. Davis L. E., Drachman D. B. Myeloma neuropathy. Successful treatment of two patients and review of cases. Arch Neurol. 1972 Dec;27(6):507–511. doi: 10.1001/archneur.1972.00490180043010. [DOI] [PubMed] [Google Scholar]
  6. Dellagi K., Brouet J. C., Danon F. Cross-idiotypic antigens among monoclonal immunoglobulin M from patients with Waldenström's macroglobulinemia and polyneuropathy. J Clin Invest. 1979 Nov;64(5):1530–1534. doi: 10.1172/JCI109612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fitting J. W., Bischoff A., Regli F., De Crousaz G. Neuropathy, amyloidosis, and monoclonal gammopathy. J Neurol Neurosurg Psychiatry. 1979 Mar;42(3):193–202. doi: 10.1136/jnnp.42.3.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fowler H., Vulpe M., Marks G., Egolf C., Dau P. C. Recovery from chronic progressive polyneuropathy after treatment with plasma exchange and cyclophosphamide. Lancet. 1979 Dec 1;2(8153):1193–1193. doi: 10.1016/s0140-6736(79)92423-1. [DOI] [PubMed] [Google Scholar]
  9. Iwashita H., Argyrakis A., Lowitzsch K., Spaar F. W. Polyneuropathy in Waldenström's macroglobulinaemia. J Neurol Sci. 1974 Mar;21(3):341–354. doi: 10.1016/0022-510x(74)90178-6. [DOI] [PubMed] [Google Scholar]
  10. Jensen K. B. Metabolism of human gamma-macroglobulin (IgM) in normal man. Scand J Clin Lab Invest. 1969 Oct;24(3):205–214. doi: 10.3109/00365516909080154. [DOI] [PubMed] [Google Scholar]
  11. Kahn S. N., Riches P. G., Kohn J. Paraproteinaemia in neurological disease: incidence, associations, and classification of monoclonal immunoglobulins. J Clin Pathol. 1980 Jul;33(7):617–621. doi: 10.1136/jcp.33.7.617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Latov N., Sherman W. H., Nemni R., Galassi G., Shyong J. S., Penn A. S., Chess L., Olarte M. R., Rowland L. P., Osserman E. F. Plasma-cell dyscrasia and peripheral neuropathy with a monoclonal antibody to peripheral-nerve myelin. N Engl J Med. 1980 Sep 11;303(11):618–621. doi: 10.1056/NEJM198009113031105. [DOI] [PubMed] [Google Scholar]
  13. MILLER D. Heparin precipitability of the macroglobulin in a patient with Waldenstrom's macroglobulinemia. Blood. 1960 Sep;16:1313–1317. [PubMed] [Google Scholar]
  14. Nemni R., Galassi G., Latov N., Sherman W. H., Olarte M. R., Hays A. P. Polyneuropathy in nonmalignant IgM plasma cell dyscrasia: a morphological study. Ann Neurol. 1983 Jul;14(1):43–54. doi: 10.1002/ana.410140108. [DOI] [PubMed] [Google Scholar]
  15. Propp R. P., Means E., Deibel R., Sherer G., Barron K. Waldenström's macroglobulinemia and neuropathy. Deposition of M-component on myelin sheaths. Neurology. 1975 Oct;25(10):980–988. doi: 10.1212/wnl.25.10.980. [DOI] [PubMed] [Google Scholar]
  16. Read D. J., Vanhegan R. I., Matthews W. B. Peripheral neuropathy and benign IgG paraproteinaemia. J Neurol Neurosurg Psychiatry. 1978 Mar;41(3):215–219. doi: 10.1136/jnnp.41.3.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. SILVERSTEIN A., DONIGER D. E. NEUROLOGIC COMPLICATIONS OF MYELOMATOSIS. Arch Neurol. 1963 Nov;9:534–544. doi: 10.1001/archneur.1963.00460110102011. [DOI] [PubMed] [Google Scholar]
  18. Salvaggio J., Arquembourg P., Bickers J., Bice D. The effect of prolonged plasmapheresis on immunoglobulins, other serum proteins, delayed hypersensitivity and phytohemagglutinin-induced lymphocyte transformation. Int Arch Allergy Appl Immunol. 1971;41(6):883–894. doi: 10.1159/000230580. [DOI] [PubMed] [Google Scholar]
  19. Sherman W. H., Latov N., Hays A. P., Takatsu M., Nemni R., Galassi G., Osserman E. F. Monoclonal IgM kappa antibody precipitating with chondroitin sulfate C from patients with axonal polyneuropathy and epidermolysis. Neurology. 1983 Feb;33(2):192–201. doi: 10.1212/wnl.33.2.192. [DOI] [PubMed] [Google Scholar]
  20. Wall R. L., Clausen K. P. Carcinoma of the urinary bladder in patients receiving cyclophosphamide. N Engl J Med. 1975 Aug 7;293(6):271–273. doi: 10.1056/NEJM197508072930604. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES